Thomas Charles Chelimsky, MD       Thomas Charles Chelimsky, MD

Professor


Specialty

  • Autonomic Disorders

Education

  • 1974-79 - Harvard University, SB cum laude, Biochemistry, June 7, 1979
  • Department of Neurology Best Doctors 20141979-83 - Washington University, MD, May 20, 1983
  • 1983-86 - Mayo Clinic, Residency, Internal Medicine
  • 1986-89 - Mayo Clinic, Residency, Neurology
  • 1986-87 - Mayo Clinic, Fellowship, Autonomic Research
  • 1989-90 - Mayo Clinic, Electromyography

Licensure and Certifications

  • American Board of Internal Medicine
  • American Board of Neurology and Psychiatry (ABPN)
  • American Board of Electrodiagnostic Medicine
  • Added Qualification in Clinical Neurophysiology (ABPN)
  • Added Qualification in Pain Management (ABPN)

Previous Principal Academic Appointments

  • Professor of Neurology, Case Western Reserve University School of Medicine, Cleveland, OH 2007-2011
  • Professor of Anesthesiology (Pain Medicine),Case Western Reserve University School of Medicine, Cleveland, OH 2007 –2011
  • Professor of Pediatrics   Case Western Reserve University School of Medicine, Cleveland, OH 2007 -2011
  • Associate Professor of Neurology Case Western Reserve University School of Medicine, Cleveland, OH 2003-2007
  • Assistant Professor of Neurology Case Western Reserve University School of Medicine, Cleveland, OH 1990-2003

Honors and Awards

  • Scholarship in Teaching Award, Case Medical School 2006 for 4PCP Project
  • SAGES Presidential Fellow 2004
  • UH Pain Program CARF 3-year Accreditation 2004: “National Leader”
  • Best Doctors in America 2001-2011
  • UH Pain Program CARF 3-year Accreditation 1997: “Model for the Nation”

Memberships in Professional Organizations

  • American Autonomic Society
  • American College of Physicians
  • American Academy of Neurology
  • American Association of Electrodiagnostic Medicine
  • International Association for the Study of Pain

Professional Service

International

  • External Reviewer, Dutch Ministry of Health Care, Welfare and Sport - The Netherlands Organisation for Health Research and Development (ZonMw). 10/2003
  • External Reviewer, Austrian Science Fund, Vienna (Fonds zur Förderung der wissenschaftlichen Forschung (FWF) Weyringergasse 35 A 1040 Wien). 2/2004

National

Federal

  • Independent Medical Monitor for Double-Blind Placebo Controlled Treatment Trial of MSA with Rifampicin.  Funded By NINDS. U54 (PI: David Robertson) And P01 (PI, Phillip Low).  Sep 2010 – trial completion.
  • NIH Study Section: Somatosensory and chemosensory systems study section (SCS) 2/2010, San Diego
  • NIH ARA Challenge Grant Reviewer, 2009
  • Member and Acting Chair, NIH Study Section Special Emphasis Panel ZRG1 CFS; Chronic Fatigue Syndrome/Fibromyalgia Syndrome 7/2000-2007
  • Member, NIH (NINDS) Study Section Special Emphasis Panel ZNS1 SRB-A; Autonomic Disorders 2005, 2009.
  • External reviewer, VA Merit Awards: 2002

Non-Federal

(AAN = American Academy of Neurology; AAS = American Autonomic Society)

  • Secretary/Treasurer, AAS, 2010
  • Board of Directors, UCNS 2010-2012
  • Consensus Panel Member, Orthostatic Hypotension Definition, 2010
  • Co-Chair, AAN autonomic scientific session, April 2010, Toronto
  • Chair, UCNS autonomic fellowship accreditation committee, 2009
  • Educational Subcommittee Topic Work Group Member for Neuromuscular, AAN 2008-
  • Chair-elect, AAN Pain Section, 2007-2009
  • Board of Directors, AAS, 2007-2010
  • Abstract reviewer, AAN Scientific Session, 2007
  • Abstract reviewer,  AAN,  2010
  • Co-Chair AAS Scientific Session “Music and the ANS”, 2007 Vienna
  • Co-Chair AAS Scientific Session, 2006
  • Chair, AAN Autonomic Section 2004-2007
  • Vice-Chair, AAN Autonomic Section 2002-2004
  • Member of Board of Directors, National Multiple System Atrophy Association, 2000-
  • Councilor, AAN Pain Section 2005-2007
  • Chairman, AAN Scientific Session; Autonomic Section, 2000-2001
  • Abstract Reviewer, AAN Scientific Session; Autonomic Section 2000-2003
  • Secretary-Treasurer, AAN Autonomic Section 2000-2001
  • Webmaster, AAN Autonomic Section, 1999-2003

University

  • Neurology Faculty Representative, Faculty Council, School of Medicine,
  • Case Western Reserve University, 2007-2011
  • Interviewer for Medical School Applicants, School of Medicine Admissions Committee, 2005
  • Member, Tenure and Promotions Committee, Department of Neurology,
  • Case Western Reserve University, 1992-1995; 2003
  • Director, Extramural teaching and speaker's bureau, Department of Neurology, University Hospitals of Cleveland 1992-1996

Hospital

  • Chairman, Credentialing Committee, Department of Neurology
  • University Hospitals of Cleveland, 1992-2007
  • Chairman, Rehabilitation Services Advisory Committee
  • University Hospitals of Cleveland, 1995-2003
  • Member, Medical Records Committee
  • University Hospitals of Cleveland, 1993-2003

Editorial Boards and Referee Duties

  • Associate Editor: Frontiers in Autonomic Neuroscience   2010-
  • Ad Hoc Reviewer for Neurology  1989-
  • Ad Hoc Reviewer for NEJM  2007-
  • Ad Hoc Reviewer for Annals of Neurology  2002-
  • Ad Hoc Reviewer for The Journal of Neurosurgery 1991-97
  • Ad Hoc Reviewer for Mayo Clinic Proceedings 1991-96
  • Ad Hoc Reviewer for Clinical Autonomic Research 1996-
  • Ad Hoc Reviewer for Autonomic Neuroscience  1999-
  • Ad Hoc Reviewer for JPNS 1996-98
  • Ad Hoc Reviewer for Archives of Neurology  2000-
  • Ad Hoc Reviewer for JNNP 2002-
  • Ad Hoc Reviewer for Annals of Family Medicine 2002-
  • Ad Hoc Reviewer for J Dermatologic Science 2003-
  • Ad Hoc Reviewer for Diabetes 2003-

Past and Present Research Support

CTSC grant from Case Western Reserve University.  Electroconvulsive therapy in multiple system atrophy.  6/1/11 to 5/31/12.  Thomas Chelimsky PI. $50k over 1 year.

Principle Investigator R01-DK083538  NIH NIDDK  Interstitial Cystitis Elucidation of Psychophysiologic and Autonomic Characteristics (ICEPAC).  7/1/09 to 6/30/14.  $3,734,188 over 5 years.  Co-Investigators: Buffington CAT, Janata, J

Co-PI R13NS073226-01 (NINDS), $15,000 Primary Care Workshop in Autonomic Disorders and Syncope Marco Island, November 2010

Research Mentor, Brain-Heart Institute Award (5% effort); “Central Autonomic Regulation in Complex Regional Pain Syndrome” $150,000; 1/1/09 to 1/1/11.  PI Chemali, K

Double-blind placebo-controlled trial of rasagiline as neuroprotective agent in multiple system atrophy.  Teva Pharmaceuticals; Sid Gilman study director. 7/1/10 – Study termination.

Principle Investigator Fishbein Family IC Research Foundation (5% effort): "Familial Aggregation of Interstitial Cystitis with Other Functional Autonomic Disorders" $28,668; 10/1/07 to 9/30/08 Co-investigators: Buffington, T; Rackley, R.

Principle Investigator (40% effort) funded by Josiah Macy Jr. Foundation, NY, “A controlled study of an interdisciplinary pain management approach led by primary care physicians”  The 4PCP trial (Primary Practice Program for Patients with Chronic Pain).  $983,076. 7/1/04 to 6/30/09.

Double-blind placebo-controlled trial of Droxidopa (L-3,4-DOPS) in orthostatic hypotension.  Chelsea Pharmaceuticals study investigator (5% effort).  3/1/08 to study termination.  H Kaufman study director.

Site Principle Investigator (approx 5% effort), NIH multi-center study, P01 NS44233 “The pathogenesis and diagnosis of multiple system atrophy”; Project P.I. Cliff Shults, MD (UCSD Dept of Neuroscience).  7/1/03 to 6/30/06.

Shire 404 study investigator (approx 3% effort):  “A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Crossover Study to Assess the Clinical Benefit of Midodrine Hydrochloride in Subjects with Moderate to Severe Neurogenic Orthostatic Hypotension” (Protocol SPD426.404).  10/1/04 to 4/30/05.

Shire 401 study investigator (approx 5% effort): “A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Crossover Study to Assess the Clinical Benefit of Midodrine Hydrochloride in Subjects with Neurogenic Orthostatic Hypotension” (Protocol 20,762-401).  10/1/03 to 1/15/05.

Roberts Pharmaceutical Corporation (approx 5% effort): Phase 3 Study of Midodrine Hydrochloride in Subjects with Neurogenic Orthostatic Hypotension.  7/1/94 to 6/1/95.

Case Research Development Grant (RIG - $5000): Autonomic Changes in Patients with Arthritic Limb Pain.  7/1/93 to 7/1/94.


Recent Publications

 

Medical College of Wisconsin
8701 Watertown Plank Road
Milwaukee, WI 53226
(414) 955-8296
Directions & Maps
© 2014

Page Updated 11/19/2014
Top